A phase II trial of biweekly oxaliplatin with simplified schedule of 48-h infusion of high-dose 5-fluorouracil and leucorvin for advanced biliary tract carcinoma

Cancer Chemotherapy and Pharmacology

Volumn 65, Issue 1, 2009, Pages 151-157

  Chen, Jen Shi ^a   Chao, Yee ^b   Yang, Tseng Sheng ^a   Chou, Wen Chi ^a   Chen, Li Tzong ^c   Lee, Kuan Der ^d   Lin, Yang Chung ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^d CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

5 Fluorouracil; Biliary tract cancer; Chemotherapy; Leucovorin; Oxaliplatin

Indexed keywords

FLUOROURACIL; FOLINIC ACID; OXALIP; OXALIPLATIN; UNCLASSIFIED DRUG;

ADULT; ADVANCED CANCER; AGED; ANEMIA; ARTICLE; BILE DUCT CARCINOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER GROWTH; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; DIARRHEA; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG MEGADOSE; DRUG SAFETY; DRUG WITHDRAWAL; FATIGUE; FEMALE; HAND FOOT SYNDROME; HUMAN; LEUKOPENIA; LIVER FUNCTION; MALE; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUROPATHY; NEUTROPENIA; PATIENT COMPLIANCE; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SIDE EFFECT; STOMATITIS; THROMBOCYTOPENIA; TREATMENT RESPONSE; VOMITING;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BILIARY TRACT NEOPLASMS; DISEASE PROGRESSION; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOROURACIL; GLUCOSE; HUMANS; LEUCOVORIN; MALE; MIDDLE AGED; ORGANOPLATINUM COMPOUNDS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 70349617463     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-009-1018-5     Document Type: Article

References (24)

1. M Hejna M Pruckmayer M Raderer 1998 The role of chemotherapy and radiation in the management of biliary cancer: a review of the literature Eur J Cancer 34 977 986 9849443 10.1016/S0959-8049(97)10166-6 1:CAS:528: DyaK1cXks1Gmsb0%3D (Pubitemid 28308335)
2. SA Khan HC Thomas VR Davidson SD Taylor-Rabinson 2005 Cholangiocarcinoma Lancet 366 1303 1314 16214602 10.1016/S0140-6736(05)67530-7 (Pubitemid 41416587)
3. SH Hall RS Benjamin WK Murphy M Valdivieso GP Bodey 1979 Adriamycin. BCNU, ftorafur chemotherapy of pancreatic, biliary tract cancer Cancer 44 2008 2013 389404 10.1002/1097-0142(197912)44:6<2008::AID-CNCR2820440607>3.0. CO;2-E 1:STN:280:DyaL3c%2Fms1yrtw%3D%3D (Pubitemid 10210825)
4. JH Harvey FP Smith PS Schein 1984 5-Fluorouracil, mitomycin, doxorubicin (FAM) in carcinoma of the biliary tract J Clin Oncol 2 1245 1248 6092556 1:STN:280:DyaL2M%2Fjt1yjtg%3D%3D
5. G Falkson JM MacIntrne CG Moertel 1984 Eastern cooperative oncology group experience with chemotherapy for inoperable gallbladder and bile duct cancer Cancer 54 965 969 6235908 10.1002/1097-0142(19840915)54:6<965::AID- CNCR2820540603>3.0.CO;2-X 1:STN:280:DyaL2c3ot1ahtA%3D%3D
6. T Takada H Kato T Matsushiro Y Nimura T Nagakawa T Nakayama 1994 Comparison of 5-fluorouracil, doxorubicin and mitomycin C with 5-fluorouracil alone in the treatment of pancreatic-biliary carcinoma Oncology 51 396 400 8052479 10.1159/000227373 1:STN:280:DyaK2czivFektg%3D%3D
7. The Advanced Colorectal Cancer Meta-Analysis Project 1992 Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate J Clin Oncol 10 896 903
8. JS Chen YY Jan YC Lin HM Wang WC Chang CT Liau 1998 Weekly 24 hour infusion of high-dose 5-fluorouracil and leucovorin in patients with biliary tract carcinomas Anticancer Drugs 9 393 398 9660535 10.1097/00001813-199806000- 00004 1:CAS:528:DyaK1cXktFOjt7w%3D (Pubitemid 28271969)
9. JS Chen YC Lin YY Jan CT Liau 2001 Mitomycin with weekly 24 hour infusion of high-dose 5-fluorouracil and leucovorin in patients with biliary tract carcinomas Anticancer Drugs 12 339 343 11335790 10.1097/00001813-200104000-00006 1:CAS:528:DC%2BD3MXktVSks74%3D (Pubitemid 32453439)
10. J Taieb E Mitry V Boige P Artru J Ezenfis T Lecomte MC Clavero-Fabri JN Vaillant P Rougier M Ducreux 2002 Optimization of 5-fluorouracil (5-FU)/Cisplatin combination chemotherapy with a new schedule of leucorvin, 5-FU and Cisplatin (LV5FU2-P regimen) in patients with biliary tract carcinoma Ann Oncol 13 1192 1196 12181241 10.1093/annonc/mdf201 1:STN:280: DC%2BD38visVertQ%3D%3D (Pubitemid 34960126)
11. E Raymond C Buquet-Fagot S Djelloul J Mester E Cvitkovic P Allain C Louvet C Gespach 1997 Antitumor activity of oxaliplatin in combination with 5-fluorouracil and the thymidylate synthase inhibitor AG337 in human colon, breast, and ovarian cancers Anticancer Drugs 8 876 885 9402315 10.1097/00001813-199710000-00009 1:CAS:528:DyaK2sXnslehsb8%3D (Pubitemid 27487802)
12. Y Becouarn C Agostini N Trufflandier V Boulanger 2001 Oxaliplatin: available data in non-colorectal gastrointestinal malignancies Crit Rev Oncol Hematol 40 265 272 11738949 10.1016/S1040-8428(01)00169-X 1:STN:280: DC%2BD3MnptFClsg%3D%3D (Pubitemid 33111071)
13. DM Kweekel H Gelderblom HJ Guchelaar 2005 Pharmacology of oxaliplatin and the use of pharmacogenomics to individualize therapy Cancer Treat Rev 31 90 105 15847979 10.1016/j.ctrv.2004.12.006 1:CAS:528:DC%2BD2MXjsVems7k%3D (Pubitemid 40542888)
14. H Kelly RM Goldberg 2005 Systemic chemotherapy for metastatic colorectal cancer: current options, current evidence J Clin Oncol 23 4553 4560 16002847 10.1200/JCO.2005.17.749 1:CAS:528:DC%2BD2MXnsl2ksLs%3D (Pubitemid 46196586)
15. O Nehls B Klump HT Arkenau HG Hass A Greschniok M Gregor R Porschen 2002 Oxaliplatin, fluorouracil and leucovorin for advanced biliary system adenocarcinoma: a prospective phase II trial Br J Cancer 87 702 704 12232749 10.1038/sj.bjc.6600543 1:CAS:528:DC%2BD38XmvF2ks70%3D (Pubitemid 35178744)
16. PC de Groen GJ Gores NF LaRusso LL Gunderson DM Nagorney 1999 Biliary tract cancer N Engl J Med 341 18 1368 1378 10536130 10.1056/NEJM199910283411807 (Pubitemid 29503577)
17. M Ducreux E Van Cutsem JL Van Laethem TM Gress K Jeziorski P Rougier T Wagener O Anak B Baron B Nordlinger 2005 EORTC Gastro Intestinal Tract Cancer Group. A randomised phase II trial of weekly high-dose 5-fluorouracil with and without folinic acid and cisplatin in patients with advanced biliary tract carcinoma: results of the 40955 EORTC trial Eur J Cancer 41 398 403 15691639 10.1016/j.ejca.2004.10.026 1:CAS:528:DC%2BD2MXhtVGqtLg%3D (Pubitemid 40187211)
18. O Nehls H Oettle JT Hartmann RD Hofheinz HG Hass MS Horger U Koppenhofer A Hochhaus J Stieler J Trojan M Gregor B Klump 2008 Capecitabine plus oxaliplatin as first-line treatment in patients with advanced biliary system adenocarcinoma: a prospective multicentre phase II trial Br J Cancer 98 309 315 18182984 10.1038/sj.bjc.6604178 1:CAS:528:DC%2BD1cXhtVGqsbY%3D (Pubitemid 351161262)
19. MY Lee MH Yang JH Liu CC Yen PC Lin HW Teng WS Wang TJ Chiou PM Chen 2007 Severe anaphylactic reactions in patients receiving oxaliplatin therapy: a rare but potentially fatal complication Support Care Cancer 15 89 93 16865410 10.1007/s00520-006-0107-9 (Pubitemid 46088318)
20. J Harder B Riecken O Kummer C Lohrmann F Otto H Usadel M Geissler O Opitz H Henb 2006 Outpatient chemotherapy with gemcitabine and oxaliplatin in patients with biliary tract cancer Br J Cancer 95 848 852 16969352 10.1038/sj.bjc.6603334 1:CAS:528:DC%2BD28XhtVans7jK (Pubitemid 44498100)
21. T Andre JM Reyes-Vidal L Fartoux P Ross M Leslie O Rosmorduc MR Clemens C Louvet N Perez F Mehmud W Scheithauer 2008 Gemcitabine and oxaliplatin in advanced biliary tract carcinoma: a phase II study Br J Cancer 99 862 867 19238628 10.1038/sj.bjc.6604628 1:CAS:528:DC%2BD1cXhtV2jurvN
22. C Hsu YC Shen CH Yang KH Yeh YS Lu CH Hsu HT Liu CC Li JS Chen CY Wu AL Cheng 2004 Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/leucovorin for locally advanced or metastatic carcinoma of the biliary tract Br J Cancer 90 1715 1719 15150619 1:CAS:528:DC%2BD2cXkvFWlur4%3D
23. F Eckel RM Schmid 2007 Chemotherapy in advanced biliary tract carcinoma: a pooled analysis of clinical trials Br J Cancer 96 896 902 17325704 10.1038/sj.bjc.6603648 1:CAS:528:DC%2BD2sXjt1SrsLw%3D (Pubitemid 46452283)
24. PA Philip MR Mahoney C Allmer J Thomas HC Pitot G Kim RC Donehower T Fitch J Picus C Erlichman 2006 Phase II study of erlotinib in patients with advanced biliary cancer J Clin Oncol 24 3069 3074 16809731 10.1200/JCO.2005.05. 3579 1:CAS:528:DC%2BD28XnslKhs70%3D (Pubitemid 46638942)